Persephone Biosciences
Focus: Persephone Biosciences is a San Diego-based public biotech company leveraging microbiome analysis to discover cancer treatments and develop therapeutic interventions. The company operates at the intersection of oncology and microbiome science with a diversified pipeline spanning vaccines, probiotics, and immunotherapies.
Profile data last refreshed 5h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
0
About Persephone Biosciences
AI assessmentNot HiringNo open roles listed right now. Follow Persephone Biosciences to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Persephone Biosciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Immunotherapy
Non-small Cell Lung CancerClinical Trials (1)
NCT04638751ARGONAUT: Stool and Blood Sample Bank for Cancer Patients
N/AHelp build intelligence for Persephone Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.